Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2 - Docwire News
Doc Wire News,
This article was originally published here Trials. 2021 Aug 23;22(1):561. doi: 10.1186/s13063-021-05538-5.